Literature DB >> 26303083

Estrogen receptor alpha and beta in health and disease.

Min Jia1, Karin Dahlman-Wright2, Jan-Åke Gustafsson3.   

Abstract

Estrogen receptors alpha (ERα) and beta (ERβ) are transcription factors that are involved in the regulation of many complex physiological processes in humans. Abnormal ER signaling leads to development of a variety of diseases, such as cancer, metabolic and cardiovascular disease, neurodegeneration, inflammation, and osteoporosis. This review provides an overview and update on ERα and ERβ in health and disease with focus on their role in cancer and metabolic disease and in the context of recent years' success in providing genome wide data on ER function. Furthermore, potential clinical applications and challenges are also discussed.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  cancer; estrogen receptors; metabolic disease

Mesh:

Substances:

Year:  2015        PMID: 26303083     DOI: 10.1016/j.beem.2015.04.008

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  131 in total

1.  Estrogen receptors differentially regulate intracellular calcium handling in human nonasthmatic and asthmatic airway smooth muscle cells.

Authors:  Sangeeta Bhallamudi; Jennifer Connell; Christina M Pabelick; Y S Prakash; Venkatachalem Sathish
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-10-16       Impact factor: 5.464

2.  ERα Binding by Transcription Factors NFIB and YBX1 Enables FGFR2 Signaling to Modulate Estrogen Responsiveness in Breast Cancer.

Authors:  Thomas M Campbell; Mauro A A Castro; Kelin Gonçalves de Oliveira; Bruce A J Ponder; Kerstin B Meyer
Journal:  Cancer Res       Date:  2017-11-27       Impact factor: 12.701

Review 3.  Prohibitin: A hypothetical target for sex-based new therapeutics for metabolic and immune diseases.

Authors:  Suresh Mishra; Bl Grégoire Nyomba
Journal:  Exp Biol Med (Maywood)       Date:  2019-02-04

Review 4.  Strategies to avoid treatment-induced lineage crisis in advanced prostate cancer.

Authors:  Guilhem Roubaud; Bobby C Liaw; William K Oh; David J Mulholland
Journal:  Nat Rev Clin Oncol       Date:  2016-11-22       Impact factor: 66.675

Review 5.  G-Protein-Coupled Estrogen Receptor (GPER) and Sex-Specific Metabolic Homeostasis.

Authors:  Geetanjali Sharma; Eric R Prossnitz
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

6.  Intermittent fasting protects against the deterioration of cognitive function, energy metabolism and dyslipidemia in Alzheimer's disease-induced estrogen deficient rats.

Authors:  Bae Kun Shin; Suna Kang; Da Sol Kim; Sunmin Park
Journal:  Exp Biol Med (Maywood)       Date:  2018-01-07

7.  Potential interference of aluminum chlorohydrate with estrogen receptor signaling in breast cancer cells.

Authors:  Vyron A Gorgogietas; Ioannis Tsialtas; Natalie Sotiriou; Vasiliki C Laschou; Aikaterini G Karra; Demetres D Leonidas; George P Chrousos; Evagelia Protopapa; Anna-Maria G Psarra
Journal:  J Mol Biochem       Date:  2018

Review 8.  Botanicals and Their Bioactive Phytochemicals for Women's Health.

Authors:  Birgit M Dietz; Atieh Hajirahimkhan; Tareisha L Dunlap; Judy L Bolton
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

9.  Estrogen receptor β controls proliferation of enteric glia and differentiation of neurons in the myenteric plexus after damage.

Authors:  F D'Errico; G Goverse; Y Dai; W Wu; M Stakenborg; E Labeeuw; V De Simone; B Verstockt; P J Gomez-Pinilla; M Warner; A Di Leo; G Matteoli; J A Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-14       Impact factor: 11.205

10.  Icariin exerts estrogen-like activity in ameliorating EAE via mediating estrogen receptor β, modulating HPA function and glucocorticoid receptor expression.

Authors:  Zhisheng Wei; Mengxia Wang; Mingfan Hong; Shengpeng Diao; Aiqun Liu; Yeqing Huang; Qingyun Yu; Zhongxing Peng
Journal:  Am J Transl Res       Date:  2016-04-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.